Literature DB >> 25298073

Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.

Masayoshi Kobayashi1, Masayuki Sugimoto, Kimihiro Komori.   

Abstract

Buerger's disease (thromboangiitis obliterans) is considered to be a nonatherosclerotic, inflammatory, and vaso-occlusive disease, although the details of the mechanisms of pathogenesis remain unknown. The occurrence of the disease is strongly related to tobacco abuse and its progression is closely linked to continued smoking. The purpose of this review article is to demonstrate the pathological characteristics of arteries affected with Buerger's disease from a possible immunoreactive point of view. In addition, we present the mechanisms for preserving the architecture of the arterial wall in affected vasculatures. Thereafter, we discuss the possibility that the pathogenesis of Buerger's disease is a type of endarteritis obliterans, deeply connected to the Notch pathway, distinct from arteriosclerosis obliterans and other vasculitides.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25298073     DOI: 10.1253/circj.cj-14-0656

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  The IL-33/sST2 Axis in Thromboangiitis Obliterans.

Authors:  Hiva Sharebiani; Mehran Mohareri; Ali Mirhosseini; Bahare Fazeli
Journal:  J Inflamm Res       Date:  2020-07-16

Review 2.  Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature.

Authors:  Javier Narváez; Carmen García-Gómez; Lorenzo Álvarez; Pilar Santo; María Aparicio; María Pascual; Mercè López de Recalde; Helena Borrell; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

3.  A Five-Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis-Induced No-Option Critical Limb Ischemia.

Authors:  Yuan Fang; Zheng Wei; Bin Chen; Tianyue Pan; Shiyang Gu; Peng Liu; Daqiao Guo; Xin Xu; Junhao Jiang; Jue Yang; Zhenyu Shi; Ting Zhu; Yun Shi; Yifan Liu; Zhihui Dong; Weiguo Fu
Journal:  Stem Cells Transl Med       Date:  2018-04-30       Impact factor: 6.940

4.  Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia.

Authors:  Xiaolang Jiang; Hao Liu; Tianyue Pan; Shiyang Gu; Yuan Fang; Zheng Wei; Gang Fang; Bin Chen; Junhao Jiang; Yun Shi; Peng Liu; Weiguo Fu; Zhihui Dong
Journal:  Front Cardiovasc Med       Date:  2021-12-06

5.  An Unusual Case of Buerger's Disease in a Pregnant Female.

Authors:  Zalak V Karena; Aditya D Mehta; Rajvee Rao; Nandan Gowda; Vishnu A Gadhia
Journal:  Cureus       Date:  2022-08-25

6.  The Association of HLA-A, B and DRB1 with Buerger's Disease.

Authors:  Abbas Shapouri-Moghaddam; Mojgan Mohammadi; Hamid Reza Rahimi; Habibolah Esmaeili; Mahmoud Mahmoudi; Mohammad-Hadi Saeed Modaghegh; Jalil Tavakol Afshari
Journal:  Rep Biochem Mol Biol       Date:  2019-07

7.  Three-year outcomes of peripheral blood mononuclear cells vs purified CD34+ cells in the treatment of angiitis-induced no-option critical limb ischemia and a cost-effectiveness assessment: A randomized single-blinded noninferiority trial.

Authors:  Hao Liu; Tianyue Pan; Yuan Fang; Gang Fang; Yifan Liu; Xiaolang Jiang; Bin Chen; Zheng Wei; Shiyang Gu; Peng Liu; Weiguo Fu; Zhihui Dong
Journal:  Stem Cells Transl Med       Date:  2021-01-05       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.